OpenAlex
PricingAboutJobs
Log inGet started
Work

Annualized Relapse Rate of First-Line Treatments for Multiple Sclerosis: A Meta-Analysis, Including Indirect Comparisons Versus Fingolimod (P01.136)

HTML

Year: 2012
Type: conference-abstract
Source: Neurology
DOI: 10.1212/wnl.78.1_meetingabstracts.p01.136
Authors: D. Tyas, N. Roskell, E. Zimovetz, C. Rycroft, B. Eckert
Institutions: Novartis (United Kingdom), RTI Health Solutions
Language: English

Topic: Multiple Sclerosis Research Studies
Subfield: Clinical Neurology
Field: Medicine
Domain: Health Sciences
Keywords: relapsing-remitting multiple sclerosis, annualized relapse rate, fingolimod, interferon-beta, glatiramer acetate, disease-modifying therapy, first-line therapy, indirect comparison, network meta-analysis, relapse prevention, interferon beta-1a, interferon beta-1b, treatment effect heterogeneity
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W2017672736
Cites:
Cited by: 1
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Subscribe
Supporters
Legal
Privacy
Accessibility
Terms
Security